Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Issan, Yossi ^a   Kornowski, Ran ^a   Aravot, Dan ^a   Shainberg, Asher ^b   Laniado Schwartzman, Michal ^c   Sodhi, Komal ^d   Abraham, Nader G ^d   Hochhauser, Edith ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN TIN; TROPONIN T; METALLOPORPHYRIN; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME RELEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; ENZYME INDUCTION; EXPERIMENTAL DIABETES MELLITUS; HEART INFARCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INDUCTION; HEME OXYGENASE-1; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; METALLOPORPHYRINS; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; PROTOPORPHYRINS; RATS, SPRAGUE-DAWLEY;

EID: 84899072698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092246     Document Type: Article

References (47)

1. Tompkins AJ, Burwell LS, Digerness SB, Zaragoza C, Holman WL, et al. (2006) Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim Biophys Acta 1762: 223-231. (Pubitemid 43006028)
2. Hunter DR, Haworth RA (1979) The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch Biochem Biophys 195: 468-477. (Pubitemid 9235079)
3. Crompton M, Costi A, Hayat L (1987) Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J 245: 915-918.
4. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (Pt 2): 233-249.
5. Halestrap AP (1999) The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp 66: 181-203.
6. Halestrap AP, McStay GP, Clarke SJ (2002) The permeability transition pore complex: another view. Biochimie 84: 153-166.
7. Abraham NG, Tsenovoy PL, McClung J, Drummond GS (2008) Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des 14: 412-421. (Pubitemid 351516846)
8. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046. (Pubitemid 17049750)
9. Hill-Kapturczak N, Chang SH, Agarwal A (2002) Heme oxygenase and the kidney. DNA Cell Biol 21: 307-321. (Pubitemid 34594544)
10. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, et al. (2007) Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol 293: H3532-3541. (Pubitemid 350230897)
11. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, et al. (2005) D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111: 3126-3134. (Pubitemid 40847791)
12. Issan Y, Hochhauser E, Kornowski R, Leshem-Lev D, Lev E, et al. (2012) Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axis. Can J Cardiol 28: 728-736.
13. Hosick PA, Stec DE (2012) Heme oxygenase, a novel target for the treatment of hypertension and obesity? Am J Physiol Regul Integr Comp Physiol 302: R207-214.
14. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599. (Pubitemid 30353893)
15. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.
16. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953. (Pubitemid 32756433)
17. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, et al. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47: 1108-1116. (Pubitemid 44289168)
18. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, et al. (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106: 2767-2770. (Pubitemid 35396973)
19. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103. (Pubitemid 41486832)
20. Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939-949. (Pubitemid 40712793)
21. Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108: 1546-1551. (Pubitemid 37187778)
22. Friedman JM (2003) A war on obesity, not the obese. Science 299: 856-858.
23. Hochhauser E, Cheporko Y, Yasovich N, Pinchas L, Offen D, et al. (2007) Bax deficiency reduces infarct size and improves long-term function after myocardial infarction. Cell Biochem Biophys 47: 11-20.
24. Shneyvays V, Leshem D, Zinman T, Mamedova LK, Jacobson KA, et al. (2005) Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury. Am J Physiol Heart Circ Physiol 288: H2792-2801. (Pubitemid 40720660)
25. Shmist YA, Kamburg R, Ophir G, Kozak A, Shneyvays V, et al. (2005) N,N,N′,N′-tetrakis(2-pyridylmethyl)-ethylenediamine improves myocardial protection against ischemia by modulation of intracellular Ca2+ homeostasis. J Pharmacol Exp Ther 313: 1046-1057. (Pubitemid 40727008)
26. Emanuelov AK, Shainberg A, Chepurko Y, Kaplan D, Sagie A, et al. (2010) Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage. Biochem Pharmacol 79: 180-187.
27. Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, et al. (2003) Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 284: H2351-2359. (Pubitemid 36622451)
28. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, et al. (2008) Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57: 1526-1535.
29. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, et al. (2000) Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20: 2243-2247.
30. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, et al. (2010) Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121: 1912-1925.
31. Borger DR, Essig DA (1998) Induction of HSP 32 gene in hypoxic cardiomyocytes is attenuated by treatment with N-acetyl-L-cysteine. Am J Physiol 274: H965-973.
32. Cai C, Teng L, Vu D, He JQ, Guo Y, et al. (2012) The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem 287: 33720-33732.
33. Kawamoto S, Flynn JP, Shi Q, Sakr SW, Luo J, et al. (2011) Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo. Tissue Eng Part A 17: 1605-1614.
34. Sardana MK, Kappas A (1987) Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci U S A 84: 2464-2468. (Pubitemid 17075886)
35. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783. (Pubitemid 44453463)
36. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 114: 361-374. (Pubitemid 351397385)
37. Xu A, Vanhoutte PM (2010) Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 302: H1231-1240.
38. Sharma HS, Maulik N, Gho BC, Das DK, Verdouw PD (1996) Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Mol Cell Biochem 157: 111-116. (Pubitemid 26142443)
39. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, et al. (2002) Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602-607. (Pubitemid 34123435)
40. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, et al. (2004) Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287: H2468-2477. (Pubitemid 39557115)
41. Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60: 79-127. (Pubitemid 351439218)
42. Kleschyov AL, Wendt M, Munzel T (2002) Heme oxygenase-1-mediated protection: potential role of nonheme iron-nitric oxide complexes. Circulation 105: e196; author reply e196.
43. Hori R, Kashiba M, Toma T, Yachie A, Goda N, et al. (2002) Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. J Biol Chem 277: 10712-10718. (Pubitemid 34968199)
44. Kusmic C, L'Abbate A, Sambuceti G, Drummond G, Barsanti C, et al. (2010) Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling. J Cell Biochem 109: 1033-1044.
45. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, et al. (2009) Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 104: 1240-1252.
46. Javadov S, Karmazyn M, Escobales N (2009) Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 330: 670-678.
47. Quarrie R, Lee DS, Steinbaugh G, Cramer B, Erdahl W, et al. (2012) Ischemic preconditioning preserves mitochondrial membrane potential and limits reactive oxygen species production. J Surg Res 178: 8-17.